诺瓦瓦克斯医药

8.46
开盘价
8.54
市值
1.38B+
最高价
8.65
最低价
8.40
收盘价
8.45
成交量
3.98K+
市盈率
3.28
股息率
0.00%

诺瓦瓦克斯医药简介

Novavax公司专注于预防传染病的疫苗的发现、开发和商业化。它提供新冠肺炎、季节性流感、呼吸道合胞病毒、埃博拉病毒和中东呼吸综合征的疫苗。该公司成立于1987年,总部设在马里兰州盖瑟斯堡。

如何购买 诺瓦瓦克斯医药 (NVAX)

登录
1分钟开户

1分钟开户

仅需1分钟即可完成账户申请和验证。整个过程完全自助,支持 RockFlow App 和网页端操作。

充值资金

充值资金

账户验证完成后,您可以使用首选的支付方式向账户充值。

购买 NVAX

购买 NVAX

通过 RockFlow App 或网页端搜索 NVAX,输入您想要投资的金额,然后点击确认即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.